메뉴 건너뛰기




Volumn 10, Issue 8, 1997, Pages 1820-1823

Lung delivery of salbutamol by dry powder inhaler (Turbuhaler®) and small volume antistatic metal spacer (Airomir® CFC-free MDI plus NebuChamber®)

Author keywords

Antistatic metal spacer; Bioavailability; Chlorofluorocarbon; Deposition; Dry powder inhaler; Salbutamol

Indexed keywords

SALBUTAMOL;

EID: 0030821173     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10081820     Document Type: Article
Times cited : (16)

References (18)
  • 1
    • 0028130746 scopus 로고
    • Metered-dose inhalers and CFCs: What respiratory physicians need to know
    • Partridge MR. Metered-dose inhalers and CFCs: what respiratory physicians need to know. Respir Med 1994; 88: 645-647.
    • (1994) Respir Med , vol.88 , pp. 645-647
    • Partridge, M.R.1
  • 2
    • 0029125012 scopus 로고
    • Aerosol particle generation from dry powder inhalers: Can they equal pressurised metered-dose inhalers?
    • Olsson B. Aerosol particle generation from dry powder inhalers: Can they equal pressurised metered-dose inhalers? J Aerosol Med 1995; 8 (Suppl. 3): S13-S18.
    • (1995) J Aerosol Med , vol.8 , Issue.3 SUPPL.
    • Olsson, B.1
  • 3
    • 0028354478 scopus 로고
    • Lung deposition of budesonide inhaled via Turbuhaler®: A comparison with terbutaline sulphate in normal volunteers
    • Borgstrom L, Bondesson E, Moren F, Trofast E, Newman SP. Lung deposition of budesonide inhaled via Turbuhaler®: a comparison with terbutaline sulphate in normal volunteers. Ear Respir J 1994; 7: 68-73.
    • (1994) Ear Respir J , vol.7 , pp. 68-73
    • Borgstrom, L.1    Bondesson, E.2    Moren, F.3    Trofast, E.4    Newman, S.P.5
  • 4
    • 0028911297 scopus 로고
    • Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurised metered-dose inhaler
    • Ekstrom T, Andersson A, Skedinger M, Lindbladh C, Stahl E. Dose potency relationship of terbutaline inhaled via Turbuhaler or via a pressurised metered-dose inhaler. Ann Allergy Asthma Immunol 1995; 74: 328-332.
    • (1995) Ann Allergy Asthma Immunol , vol.74 , pp. 328-332
    • Ekstrom, T.1    Andersson, A.2    Skedinger, M.3    Lindbladh, C.4    Stahl, E.5
  • 5
    • 0029972560 scopus 로고    scopus 로고
    • The inhalation device influences lung deposition and bronchodilating effect of terbutaline
    • Borgstrom L, Derom E, Stahl E, Wahlin-Boll E, Pauwels R. The inhalation device influences lung deposition and bronchodilating effect of terbutaline. Am J Respir Crit Care Med 1996; 153: 1636-1640.
    • (1996) Am J Respir Crit Care Med , vol.153 , pp. 1636-1640
    • Borgstrom, L.1    Derom, E.2    Stahl, E.3    Wahlin-Boll, E.4    Pauwels, R.5
  • 6
    • 0029164789 scopus 로고
    • A nonelectrostatic spacer for aerosol delivery
    • Bisgaard H, Anhoj J, Klug B, Berg E. A nonelectrostatic spacer for aerosol delivery. Arch Dis Child 1995; 73: 226-230.
    • (1995) Arch Dis Child , vol.73 , pp. 226-230
    • Bisgaard, H.1    Anhoj, J.2    Klug, B.3    Berg, E.4
  • 7
    • 0029804408 scopus 로고    scopus 로고
    • Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants
    • Wildhaber JH, Devadason SG, Eber E, et al. Effect of electrostatic charge, flow, delay and multiple actuations on the in vitro delivery of salbutamol from different small volume spacers for infants. Thorax 1996; 51: 985-988.
    • (1996) Thorax , vol.51 , pp. 985-988
    • Wildhaber, J.H.1    Devadason, S.G.2    Eber, E.3
  • 8
    • 0029070370 scopus 로고
    • The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler
    • Barry PW, O'Callaghan C. The effect of delay, multiple actuations and spacer static charge on the in vitro delivery of budesonide from the Nebuhaler. Br J Clin Pharmacol 1995; 40: 76-78.
    • (1995) Br J Clin Pharmacol , vol.40 , pp. 76-78
    • Barry, P.W.1    O'Callaghan, C.2
  • 9
    • 0028133231 scopus 로고
    • Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range
    • Barry PW, O'Callaghan C. Multiple actuations of salbutamol MDI into a spacer device reduce the amount of drug recovered in the respirable range. Ear Respir J 1994; 7: 1707-1709.
    • (1994) Ear Respir J , vol.7 , pp. 1707-1709
    • Barry, P.W.1    O'Callaghan, C.2
  • 10
    • 0029823099 scopus 로고    scopus 로고
    • Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device
    • Clark DJ, Lipworth BJ. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung bioavailability of salbutamol via a spacer device. Thorax 1996; 51: 981-984.
    • (1996) Thorax , vol.51 , pp. 981-984
    • Clark, D.J.1    Lipworth, B.J.2
  • 11
    • 0029958486 scopus 로고    scopus 로고
    • Pharmacokinetics of inhaled drugs
    • Lipworth BJ. Pharmacokinetics of inhaled drugs. Br J Clin Pharmacol 1996; 42: 697-705.
    • (1996) Br J Clin Pharmacol , vol.42 , pp. 697-705
    • Lipworth, B.J.1
  • 12
    • 0029883291 scopus 로고    scopus 로고
    • Lung bioavailability of generic and innovator salbutamol MDIs
    • Chrystyn H, Corlett SA, Silkstone V. Lung bioavailability of generic and innovator salbutamol MDIs. Thorax 1996; 51: 658.
    • (1996) Thorax , vol.51 , pp. 658
    • Chrystyn, H.1    Corlett, S.A.2    Silkstone, V.3
  • 13
    • 0027362604 scopus 로고
    • 2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered-dose inhaler and modified activator device
    • 2-adrenoceptor responses and pharmacokinetics of salbutamol given by standard metered-dose inhaler and modified activator device. Br J Clin Pharmacol 1993; 36: 445-450.
    • (1993) Br J Clin Pharmacol , vol.36 , pp. 445-450
    • Newnham, D.M.1    McDevitt, D.G.2    Lipworth, B.J.3
  • 14
    • 0030000538 scopus 로고    scopus 로고
    • Lung bioavailability of chlorofluorocarbon-free, dry powder and chlorofluorocarbon-containing formulations of salbutamol
    • Clark DJ, Lipworth BJ. Lung bioavailability of chlorofluorocarbon-free, dry powder and chlorofluorocarbon-containing formulations of salbutamol. Br J Clin Pharmacol 1996; 41: 247-249.
    • (1996) Br J Clin Pharmacol , vol.41 , pp. 247-249
    • Clark, D.J.1    Lipworth, B.J.2
  • 15
    • 0029986764 scopus 로고    scopus 로고
    • Lung bioavailability of generic and innovator salbutamol metered-dose inhalers
    • Clark DJ, Gordon-Smith J, McPhate G, Clark G, Lipworth BJ. Lung bioavailability of generic and innovator salbutamol metered-dose inhalers. Thorax 1996; 51: 325-326.
    • (1996) Thorax , vol.51 , pp. 325-326
    • Clark, D.J.1    Gordon-Smith, J.2    McPhate, G.3    Clark, G.4    Lipworth, B.J.5
  • 16
    • 0024498766 scopus 로고
    • Beta-adrenoceptor responses to inhaled salbutamol in normal subjects
    • Lipworth BJ, McDevitt DG. Beta-adrenoceptor responses to inhaled salbutamol in normal subjects. Eur J Clin Pharmacol 1989; 36: 239-245.
    • (1989) Eur J Clin Pharmacol , vol.36 , pp. 239-245
    • Lipworth, B.J.1    McDevitt, D.G.2
  • 17
    • 0031027706 scopus 로고    scopus 로고
    • Dose-response of inhaled drugs in asthma: An update
    • Clark DJ, Lipworth BJ. Dose-response of inhaled drugs in asthma: an update. Clin Pharmacokinet 1997; 32: 58-74.
    • (1997) Clin Pharmacokinet , vol.32 , pp. 58-74
    • Clark, D.J.1    Lipworth, B.J.2
  • 18
    • 0027971169 scopus 로고
    • Nebuliser performance: Pharmacokinetics and systemic effects of salbutamol given via a novel nebuliser delivery system (Ventstream)
    • Newnham DM, Lipworth BJ. Nebuliser performance: pharmacokinetics and systemic effects of salbutamol given via a novel nebuliser delivery system (Ventstream). Thorax 1994; 49: 762-770.
    • (1994) Thorax , vol.49 , pp. 762-770
    • Newnham, D.M.1    Lipworth, B.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.